Revance Therapeutics, Inc.
Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including our next-generation investigational neuromodulator product, DaxibotulinumtoxinA for Injection.
201-500 employees
Biotechnology & Chemical Products
Technology Infrastructure
Digital Payments
Headquarters address
Newark
www.revance.com